Skip to main content

What is Treatment-Resistant Depression?


With strategies such as Transcranial Magnetic Stimulation (TMS), Ketamine, and psychedelics becoming more prevalent for treatment-resistant depression, it is helpful to take a look at what this entity really means. Not everyone who is being referred for either TMS or treatment with Ketamine may have "true" treatment-resistant depression and then there is what is called "pseudo-resistance."

In simple terms, treatment-resistant depression implies that depression has not reached sufficient remission after an adequate treatment. Remission is defined as clinical improvement with few signs of depression still remaining and a lower likelihood of subsequent exacerbations. About 15% of people with depression may eventually develop treatment-resistant depression (Berlim & Turecki, 2007). Treatment-resistant depression has been variously defined, but the most commonly accepted definition is as below (Souery et al., 2007):

A person with depression is considered to have treatment-resistant depression when consecutive treatments with two antidepressants from two different pharmacologic classes, used for a sufficient length of time at an adequate dose, fail to produce significant improvement. This is further elaborated below:
  • Two different pharmacologic classes means antidepressants having different mechanisms of action. For example, Selective Serotonin Reuptake Inhibitors (SSRIs) versus Serotonin Norepinephrine Reuptake Inhibitors (SNRIs).
  • An adequate length of time is an antidepressant trial lasting at least 4 weeks.
  • An adequate dose is the minimum effective daily dose recommended in the drug package insert.
  • Significant improvement is a score of less than 17 on the 17-item Hamilton Depression Rating Scale.
There are several problems with this definition of treatment-resistant depression. First, it assumes that switch from one class of antidepressant to another may be a more effective strategy than switching within the class. Second, it doesn’t talk about the role of psychotherapy. Third, it is silent on functional improvement and improvement in quality of life and relies only on clinical improvement to define treatment-resistance. Nevertheless, this is the most accepted definition of treatment-resistant depression.

What is Pseudo-Resistance?
Before you jump the gun and diagnose yourself with treatment-resistant depression, first rule out if this is pseudo-resistance. About 60% of people initially classified as having treatment-resistant depression may actually have pseudo-resistance (Berlim & Turecki, 2007). The causes of pseudo-resistance are below (Berlim & Turecki, 2007; Souery et al., 2006):  

  1. Inadequate dosing of the antidepressants: This may be due to staying at a low dose of the antidepressants because of initial side effects that have subsequently abated. Other causes could be drug interactions that are making the antidepressant less effective or an individual having rapid metabolism of the antidepressant. 
  2. Inadequate duration of the antidepressants: Switching medications too soon and concluding that a given medication is ineffective also contributes to pseudo-resistance.
  3. Inadequate adherence: Not taking the antidepressants as prescribed due to side effects or forgetting to take them accounts for about 20% of scenarios that are considered treatment-resistant depression.
  4. Improper diagnosis: This includes:
  • Failure to diagnose an underlying bipolar disorder.
  • Failure to diagnose psychotic symptoms associated with depression.
  • Failure to diagnose melancholic depression. Melancholic depression is a more severe kind of depression characterized by loss of pleasure in all, almost all activities, no emotional response when something good happens, a profound sense of despondency or despair, depression that is worse in the morning, early-morning awakening, appearing markedly slowed down or agitated, poor appetite or weight loss, and excessive or inappropriate guilt (American Psychiatric Association, 2013).
  • Failure to diagnose co-occurring anxiety or personality disorders.
  • Failure to identify underlying medical conditions that may be associated with depression such as hypothyroidism.
If you haven’t responded to a couple of trials of antidepressants, it may be worthwhile to explore the above possibilities in collaboration with your antidepressant prescriber.

What are the Risk Factors for Treatment-Resistant Depression?
While there is no definitive cause as to why some people with depression will develop treatment-resistant depression, research does demonstrate certain risk factors that predispose one to develop treatment-resistant depression. These include the following (Souery et al., 2007):
  • Co-occurring anxiety disorders, particularly panic disorder and social phobia.
  • Having suicidal thoughts during the current episode of depression.
  • Greater severity of depressive symptoms.
  • Presence of melancholic symptoms of depression (described before).
  • History of recurrent episodes of depression.
  • More than one psychiatric hospitalization in the past.
  • Age of onset of depression before 18 years.
  • Non-response to the first antidepressant in one’s lifetime.
  • Co-occurring personality disorder.
Being aware of these risk factors helps an individual plan ahead for treatment as treatment-resistant depression may require a combination of medications or other non-pharmacological strategies.

To learn more about evidence-based self-management techniques that are proven to work for depression, check out Dr. Duggal's Author Page.


HARPREET S. DUGGAL, MD, FAPA

REFERENCES:

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association.

Berlim, M. T., & Turecki, G. (2007). Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Canadian Journal of Psychiatry, 52, 46-54.

Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., & Mendlewicz, J. for the Group for the Study of Resistant Depression (GSRD) (2007). Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry, 68(7), 1062-1070.

Souery, D., Papakostas, G. I., & Trivedi, M. H. (2006). Treatment-resistant depression. Journal of Clinical Psychiatry, 67(suppl 6), 16-22.



Labels:

Comments

Post a Comment

Popular posts from this blog

10 Poor Listening Styles to Avoid

When we talk about communication, we mostly focus on speaking, writing, and reading. Listening is seldom emphasized as a primary form of communication, even though listening enables us to satisfy an individual’s deep psychological needs – to be understood, to be affirmed, to be validated, and to be appreciated (Covey, 2020). We mostly listen not to understand but to prepare response, judge, or interpret information through our own motives and frame of reference. These poor listening styles can be subsumed under these 10 categories (Covey 2014, Harvard Business Review Press, 2019): 1. Spacing out or ignoring is when you zone out because you are too preoccupied with your own thoughts. This does happen to all of us, but you don’t want to be labelled as a spacey person if this keeps happening to you.  2. Pretend or removed listening is where you may be multitasking and give the speaker the impression that you are paying attention using fillers like “yeah,” uh-huh,” “right,” “cool” or thr
Post a Comment
Read more

The Art of Everyday Mindfulness

What is Mindfulness? If your notion of mindfulness is a practice starting with a phrase like, "Take a deep breath and close your eyes," then you have mostly bought into the myth that the only effective way of practicing mindfulness is guided meditation .  However, if you know what mindfulness entails, you can incorporate it in your daily routine in an informal way without relying on popular apps that have commercialized a practice known to humans for thousands of years.  Mindfulness-based interventions are well-validated treatment approaches that not only promote well-being and resilience but also have been found to be effective in anxiety, depression, chronic pain, and substance use disorders (Wielgosz et al., 2019). Mindfulness has two components: (a) orienting one’s attention purposefully to the present moment, and (b) approaching one’s experience in the present moment with curiosity, openness, and acceptance (Bishop et al., 2004). The state of mindfulness is described as
1 comment
Read more

Value-Based Goals: The Antidote for “Success Depression”

A disconnect between your present accomplishments and your core values may make you suffer from success depression  wherein despite “having it all” (e.g., successful career, stable relationships, healthy children, etc.), you still struggle with depression and view your accomplishments as hollow (Zettle, 2007). The cure for this malaise is to clarify your core values and have goals and actions that are driven by these values. Psychotherapist Russ Harris describes values as our heart’s deepest desires for the way we want to interact with the world, other people, and ourselves. They are what we want to stand for in life, how we want to behave, what sort of person we want to be, and what sort of strengths and qualities we want to develop (Harris, 2009). Values are subjective; what one may consider as a value (e.g., being famous) may be considered as being cocky by another person. Moreover, values do change with time. For instance, you may value social popularity and raising a family
Post a Comment
Read more